The Socioeconomic Impact of Long-Acting Injectable Buprenorphine
ClinicoEconomics and Outcomes Research · 2026-05 · Volume 18 · 1-12
DOI: 10.2147/ceor.s590462 ↗Kurz gefasst
Fachartikel in der Zeitschrift ClinicoEconomics and Outcomes Research, 2026-05. Verfasst von Samuel E Rasche und 4 weiteren Autor:innen. Beteiligte Einrichtung: Edge Health, London, UK. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Edge Health, London, UK.
- School of Psychology, Liverpool John Moores University, Liverpool, UK.
- Camurus Ltd., Cambridge, UK.
ORCID-Profile: Harry R Sumnall, Daniel Mogford
Zitieren
APA
Rasche, S. E., Batchelor, G. O. W., Montgomery, C., Sumnall, H. R., & Mogford, D. (2026). The Socioeconomic Impact of Long-Acting Injectable Buprenorphine. ClinicoEconomics and Outcomes Research, Volume 18, 1-12. https://doi.org/10.2147/ceor.s590462
Vancouver
Rasche SE, Batchelor GOW, Montgomery C, Sumnall HR, Mogford D. The Socioeconomic Impact of Long-Acting Injectable Buprenorphine. ClinicoEconomics and Outcomes Research. 2026;Volume 18:1-12. doi:10.2147/ceor.s590462
BibTeX
@article{Rasche2026,
author = {Rasche, Samuel E and Batchelor, George O W and Montgomery, Catharine and Sumnall, Harry R and Mogford, Daniel},
title = {The Socioeconomic Impact of Long-Acting Injectable Buprenorphine},
journal = {ClinicoEconomics and Outcomes Research},
year = {2026},
volume = {Volume 18},
pages = {1--12},
doi = {10.2147/ceor.s590462}
}
EUVIMED